Hemsley KM - Search Results

1

Jolly RD, Dittmer KE, Garrick DJ, Chernyavtseva A, Hemsley KM, King B, Fietz M, Shackleton NM, Fairley R, Wylie K. Jolly RD, et al. Among authors: hemsley km. Vet Pathol. 2019 Sep;56(5):743-748. doi: 10.1177/0300985819839239. Epub 2019 Apr 14. Vet Pathol. 2019. PMID: 30983534

2

Validation of a heparan sulfate-derived disaccharide as a marker of accumulation in murine mucopolysaccharidosis type IIIA.

King B, Savas P, Fuller M, Hopwood J, Hemsley K. King B, et al. Mol Genet Metab. 2006 Feb;87(2):107-12. doi: 10.1016/j.ymgme.2005.09.026. Epub 2005 Dec 13. Mol Genet Metab. 2006. PMID: 16352454

3

Characterization of a C57BL/6 congenic mouse strain of mucopolysaccharidosis type IIIA.

Crawley AC, Gliddon BL, Auclair D, Brodie SL, Hirte C, King BM, Fuller M, Hemsley KM, Hopwood JJ. Crawley AC, et al. Among authors: hemsley km. Brain Res. 2006 Aug 9;1104(1):1-17. doi: 10.1016/j.brainres.2006.05.079. Epub 2006 Jul 7. Brain Res. 2006. PMID: 16828069

4

Injection of recombinant human sulfamidase into the CSF via the cerebellomedullary cistern in MPS IIIA mice.

Hemsley KM, King B, Hopwood JJ. Hemsley KM, et al. Mol Genet Metab. 2007 Mar;90(3):313-28. doi: 10.1016/j.ymgme.2006.10.005. Epub 2006 Dec 12. Mol Genet Metab. 2007. PMID: 17166757

5

Examination of intravenous and intra-CSF protein delivery for treatment of neurological disease.

Hemsley KM, Luck AJ, Crawley AC, Hassiotis S, Beard H, King B, Rozek T, Rozaklis T, Fuller M, Hopwood JJ. Hemsley KM, et al. Eur J Neurosci. 2009 Mar;29(6):1197-214. doi: 10.1111/j.1460-9568.2009.06666.x. Eur J Neurosci. 2009. PMID: 19302155

6

Effect of cisternal sulfamidase delivery in MPS IIIA Huntaway dogs--a proof of principle study.

Hemsley KM, Norman EJ, Crawley AC, Auclair D, King B, Fuller M, Lang DL, Dean CJ, Jolly RD, Hopwood JJ. Hemsley KM, et al. Mol Genet Metab. 2009 Dec;98(4):383-92. doi: 10.1016/j.ymgme.2009.07.013. Epub 2009 Jul 28. Mol Genet Metab. 2009. PMID: 19699666

7

Intracisternal enzyme replacement therapy in lysosomal storage diseases: routes of absorption into brain.

Jolly RD, Marshall NR, Perrott MR, Dittmer KE, Hemsley KM, Beard H. Jolly RD, et al. Among authors: hemsley km. Neuropathol Appl Neurobiol. 2011 Jun;37(4):414-22. doi: 10.1111/j.1365-2990.2010.01158.x. Neuropathol Appl Neurobiol. 2011. PMID: 21175738

8

Enzyme replacement reduces neuropathology in MPS IIIA dogs.

Crawley AC, Marshall N, Beard H, Hassiotis S, Walsh V, King B, Hucker N, Fuller M, Jolly RD, Hopwood JJ, Hemsley KM. Crawley AC, et al. Among authors: hemsley km. Neurobiol Dis. 2011 Aug;43(2):422-34. doi: 10.1016/j.nbd.2011.04.014. Epub 2011 Apr 29. Neurobiol Dis. 2011. PMID: 21550404

9

Treatment of canine fucosidosis by intracisternal enzyme infusion.

Kondagari GS, King BM, Thomson PC, Williamson P, Clements PR, Fuller M, Hemsley KM, Hopwood JJ, Taylor RM. Kondagari GS, et al. Among authors: hemsley km. Exp Neurol. 2011 Aug;230(2):218-26. doi: 10.1016/j.expneurol.2011.04.019. Epub 2011 May 6. Exp Neurol. 2011. PMID: 21575633

10

Intracisternal enzyme replacement therapy in lysosomal storage diseases: dispersal pathways, regional enzyme concentrations and the effect of posttreatment posture.

Jolly RD, Marshall NR, Marshall J, Hartman A, Hemsley KM, Winner LK. Jolly RD, et al. Among authors: hemsley km. Neuropathol Appl Neurobiol. 2013 Oct;39(6):681-92. doi: 10.1111/nan.12010. Neuropathol Appl Neurobiol. 2013. PMID: 23252616

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

75 results

Search Page